ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary ...
Six Hamas fighters were spotted by IDF surveillance on Tuesday, trying to surprise and ambush the military. After ...
China’s Longi says it will begin mass production of base-metal PV modules in the second quarter of 2026 as rising silver ...
The Justice Department early Tuesday released more than 11,000 additional documents and photos from the Jeffrey Epstein files ...
ImmunityBio (IBRX) stock rises as the company records over 400% YoY groiwth in Q4 net product revenue thanks to its cancer ...
Doctors and nurses blame inaction by police and the NHS for mounting toll of physical and sexual abuse ...
Red Bull Racing has revealed its 2026 livery at a launch event in Detroit as controversy continues to rumble over a loophole ...
Traditional biomanufacturing is based on microbial or mammalian cell culture, plants can be grown in bioreactors and hold ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback